Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($7,508.0) | $13.9K | $33.1K | $115.9K | $165.4K | $213.7K | $244.7K | ($5,034.2K) | $10.7M | ($20.3M) | ($62.6M) | ($38.2M) | $5,801.0K | ($148.4M) | ($170.5M) | ($107.6M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Aadi Bioscience, Inc.'s last 12-month Net Debt is ($61.7M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Aadi Bioscience, Inc.'s Net Debt growth was (47.7%). The average annual Net Debt growth rates for Aadi Bioscience, Inc. have been 16.6% over the past three years, 7.6% over the past five years.
Over the last year, Aadi Bioscience, Inc.'s Net Debt growth was (47.7%), which is lower than industry growth of (0.1%). It indicates that Aadi Bioscience, Inc.'s Net Debt growth is Good.